Free Trial

Covetrus (CVET) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
50-Day Range
52-Week Range
3 shs
Average Volume
1.34 million shs
Market Capitalization
$2.94 billion
P/E Ratio
Dividend Yield
Price Target
CVET stock logo

About Covetrus Stock (NASDAQ:CVET)

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.

CVET Stock News Headlines

CVET Historical Data
Jeff Bezos Next Trillion Dollar Bet
While the world has been obsessed with AI and ChatGPT… Jeff Bezos has quietly gone all in on a technology that's going to prove to be FAR bigger. If you've never heard of "QaaS" technology you need watch this.
Jeff Bezos Next Trillion Dollar Bet
While the world has been obsessed with AI and ChatGPT… Jeff Bezos has quietly gone all in on a technology that's going to prove to be FAR bigger. If you've never heard of "QaaS" technology you need watch this.
Covetrus, Inc. (CVET)
Covetrus Names Michelle Bonfilio as Chief People Officer
See More Headlines
Receive CVET Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covetrus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Drug Stores & Proprietary Stores
Current Symbol
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$4.58 billion
Cash Flow
$2.19 per share
Book Value
$10.97 per share


Free Float
Market Cap
$2.94 billion
Not Optionable
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Benjamin WolinMr. Benjamin Wolin (Age 46)
    Pres, CEO & Director
    Comp: $1.02M
  • Mr. Matthew J. Foulston (Age 57)
    Exec. VP & Global CFO
    Comp: $624.66k
  • Ms. Georgina Wraight (Age 47)
    Exec. VP & Pres of Global Technology Solutions
    Comp: $563.4k
  • Mr. Matthew Malenfant (Age 60)
    Chief Commercial Officer
    Comp: $533.62k
  • Ms. Rebecca Kidd (Age 53)
    Head of Operations & Operational Excellence
  • Mr. Andrew B. Coxhead (Age 53)
    VP, Corp. Controller & Chief Accounting Officer
  • Mr. Nicholas Michael Jansen
    VP of Investor Relations
  • Ms. Margie B. Pritchard
    Gen. Counsel & Corp. Sec.
  • Mr. Cameron R. Foster
    Sr. VP of Strategy & Corp. Devel.
  • Ms. Michelle Bonfilio (Age 51)
    Chief People Officer

CVET Stock Analysis - Frequently Asked Questions

How were Covetrus' earnings last quarter?

Covetrus, Inc. (NASDAQ:CVET) announced its quarterly earnings data on Sunday, February, 28th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.16 by $0.05. The business's revenue was up 11.2% compared to the same quarter last year.

What is Benjamin Wolin's approval rating as Covetrus' CEO?

25 employees have rated Covetrus Chief Executive Officer Benjamin Wolin on Benjamin Wolin has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Covetrus own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Covetrus investors own include Pfizer (PFE), NVIDIA (NVDA), Advanced Micro Devices (AMD), AT&T (T), Activision Blizzard (ATVI), Boeing (BA) and Chegg (CHGG).

This page (NASDAQ:CVET) was last updated on 7/23/2024 by Staff

From Our Partners